GT
FRTX

Glenmede Trust’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Glenmede Trust’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Hold
0
– – – 3208
2019
Q1 		– Hold
0
– – – 3210
2013
Q3 		– Sell
-30
Closed -$296K – 2276
2013
Q2 		$296K Buy
+30
New +$296K ﹤0.01% 957